R R Engel1, R Grohmann, E Rüther
1Department of Psychiatry, Ludwig-Maximilians University, Munich, Germany. Rolf.Engel@med.uni-muenchen.de
Monitoring adverse drug reactions is crucial throughout a drug's lifecycle. This paper compares methods like Prescription Event Monitoring (PEM) and the AMSP Project, analyzing their strengths, weaknesses, and potential biases for post-approval drug safety surveillance.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: